Clinical Trials in Colorado

Showing 5021-5040 of 18,143 trials

Alveolar Macrophage Programming Following Endotoxin Exposure

NCT03859050

The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).

ARDS, Human

National Jewish Health25 participantsStarted Mar 2019

Denver, Colorado, United States

TERMINATEDNA50 miles

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

NCT05093504

Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

Hemorrhage, SurgicalHemorrhage PostoperativeBlood Loss, Surgical+1 more

CytoSorbents, Inc9 participantsStarted Dec 2021

Sacramento, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +24 more locations

Alveolar Macrophage Programming Following Endotoxin Exposure

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

Find Trials by Condition in Colorado

T1D Pregnancy & Me

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

Afrezza® INHALE-1 Study in Pediatrics

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213

Examining the Effectiveness of Cognitive Training

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Contrast-enhanced Ultrasound Evaluation of Chemoembolization

CMV CTLs in Neonates With CMV Infection

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Imaging to Improve Brain Stimulation

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer